Kidney function key to new Drug's safety
NCT ID NCT06496217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the experimental drug MBX 2109 is handled by the body in people with different levels of kidney function. 25 adults with normal or impaired kidneys received a single dose. The goal was to measure safety and drug levels, not to treat a disease. Results will help decide future doses for patients with kidney issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MBX Bioscience Investigational Site
Tampa, Florida, 33603, United States
-
MBX Biosciences Investigational Site
Miami, Florida, 33136, United States
-
MBX Biosciences Investigational Site
Minneapolis, Minnesota, 55101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a damaged kidney change how antibiotics work?
- Can kidney health change how a new drug works?
- Kidney function may change how D-2570 works in the body
- Sleep drug YZJ-1139 put to the test in kidney patients
- Kidney function may change how antibiotic levornidazole acts in the body
- Kidney health may change how this drug works